EKG vs. FTXH
EKG (First Trust Nasdaq Lux Digital Health Solutions ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both Health & Biotech Equities funds from First Trust - EKG tracks the NASDAQ Lux Health Tech Index while FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Over the past 3 years, EKG returned -0.66%/yr vs 11.48%/yr for FTXH. A 0.54 correlation means they provide meaningful diversification when combined. EKG charges 0.65%/yr vs 0.60%/yr for FTXH.
Performance
EKG vs. FTXH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EKG achieves a -10.11% return, which is significantly lower than FTXH's 5.00% return.
EKG
- 1D
- -0.20%
- 1M
- 2.98%
- YTD
- -10.11%
- 6M
- -12.99%
- 1Y
- -0.93%
- 3Y*
- -0.66%
- 5Y*
- —
- 10Y*
- —
FTXH
- 1D
- 1.69%
- 1M
- 1.65%
- YTD
- 5.00%
- 6M
- 6.02%
- 1Y
- 36.24%
- 3Y*
- 11.48%
- 5Y*
- 7.80%
- 10Y*
- —
EKG vs. FTXH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | -10.11% | 11.89% | 6.53% | -0.11% | -19.59% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 5.00% | 24.15% | 2.98% | -1.41% | 4.99% |
Correlation
The correlation between EKG and FTXH is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.49 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2022 | 0.54 |
The correlation between EKG and FTXH has been stable across timeframes, ranging from 0.49 to 0.54 - a consistent structural relationship.
EKG vs. FTXH - Sectors Allocation Comparison
Sectors
EKG
FTXH
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
EKG
FTXH
Technology
EKG
FTXH
-
Basic Materials
EKG
-
FTXH
-
Communication Services
EKG
-
FTXH
-
Consumer Cyclical
EKG
-
FTXH
-
Consumer Defensive
EKG
-
FTXH
-
Energy
EKG
-
FTXH
-
Financial Services
EKG
-
FTXH
-
Industrials
EKG
-
FTXH
-
Real Estate
EKG
-
FTXH
-
Utilities
EKG
-
FTXH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EKG vs. FTXH — Risk / Return Rank
EKG
FTXH
EKG vs. FTXH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EKG | FTXH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.19 | ||
| Sortino ratioReturn per unit of downside risk | -3.07 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.37 | -0.36 |
| Calmar ratioReturn relative to maximum drawdown | -0.04 | 4.87 | -4.92 |
| Martin ratioReturn relative to average drawdown | -0.10 | 14.07 | -14.17 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EKG | FTXH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.04 | 2.14 | -2.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.48 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | 0.38 | -0.51 |
Drawdowns
EKG vs. FTXH - Drawdown Comparison
The maximum EKG drawdown since its inception was -43.82%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for EKG and FTXH.
Loading charts...
Drawdown Indicators
| EKG | FTXH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.82% | -32.11% | -11.71% |
Max Drawdown (1Y)Largest decline over 1 year | -22.09% | -7.47% | -14.62% |
Max Drawdown (3Y)Largest decline over 3 years | -34.49% | -19.51% | -14.98% |
Max Drawdown (5Y)Largest decline over 5 years | — | -19.51% | — |
Current DrawdownCurrent decline from peak | -20.78% | -2.88% | -17.90% |
Average DrawdownAverage peak-to-trough decline | -22.66% | -5.84% | -16.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.73% | 2.58% | +7.15% |
Volatility
EKG vs. FTXH - Volatility Comparison
First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) has a higher volatility of 7.09% compared to First Trust Nasdaq Pharmaceuticals ETF (FTXH) at 4.83%. This indicates that EKG's price experiences larger fluctuations and is considered to be riskier than FTXH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EKG | FTXH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.09% | 4.83% | +2.26% |
Volatility (6M)Calculated over the trailing 6-month period | 16.42% | 11.73% | +4.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.57% | 16.98% | +4.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.07% | 16.31% | +10.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.07% | 18.41% | +8.66% |
EKG vs. FTXH - Expense Ratio Comparison
EKG has a 0.65% expense ratio, which is higher than FTXH's 0.60% expense ratio.
Dividends
EKG vs. FTXH - Dividend Comparison
EKG has not paid dividends to shareholders, while FTXH's dividend yield for the trailing twelve months is around 1.22%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.22% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% |
Frequently Asked Questions
EKG and FTXH have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EKG has higher volatility (7.09%) compared to FTXH (4.83%). In terms of maximum drawdown, EKG dropped -43.82% vs FTXH's -32.11%.
On 3-year performance, FTXH leads with 11.48% vs -0.66% for EKG. On fees, FTXH is cheaper at 0.60% per year. On volatility, FTXH has been the lower-risk option at 4.83%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, FTXH has performed better with a 11.48% return vs -0.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FTXH is cheaper with a 0.60% expense ratio, compared with 0.65% for EKG.
FTXH has the higher dividend yield at 1.22%, compared with 0.00% for EKG.
EKG tracks NASDAQ Lux Health Tech Index, while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. Their fees differ too: 0.65% for EKG and 0.60% for FTXH.
FTXH currently has the higher Sharpe Ratio (2.14 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EKG and FTXH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer